Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV

This study has been completed.
Sponsor:
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00074399
First received: December 11, 2003
Last updated: August 6, 2009
Last verified: August 2009